SCHEDULE 13D/A: GoodRx Holdings to Repurchase $29.4 Million in Class A Common Stock from Major Shareholder Idea Men, LLC

Sentiment:

Share Repurchase Disclosure


GoodRx Holdings, Inc. has entered into an agreement to repurchase 7 million shares of its Class A Common Stock from Idea Men, LLC for $29.4 million, reducing the major shareholder's stake.

Summary

  • GoodRx Holdings, Inc. (the "Issuer") has entered into a Stock Purchase Agreement with Idea Men, LLC (the "Reporting Person") on March 16, 2025.
  • Under the agreement, the Reporting Person will sell an aggregate of 7,000,000 shares of Class A Common Stock to the Issuer.
  • The sale price is $4.20 per share, resulting in net proceeds of $29,400,000 for Idea Men, LLC.
  • The transaction is expected to close on March 21, 2025.
  • As of March 18, 2025, prior to the closing of this repurchase, Idea Men, LLC beneficially owned 50,164,171 shares of Class A Common Stock, representing 32.31% of the class.
  • The Reporting Person has agreed to a lock-up period, restricting the sale, transfer, or hedging of any Class A or Class B Common Stock until the completion of the second full trading day after the public release of earnings data for the quarter ended March 31, 2025.

Sentiment

Score: 7

Explanation: The transaction is a negotiated share repurchase, which can be viewed positively for the issuer as it reduces share count and for the selling shareholder as it provides liquidity. It's a planned event with clear terms, indicating a neutral to slightly positive sentiment depending on individual investor perspectives on capital allocation and shareholder liquidity.

Positives

  • For GoodRx Holdings, Inc., the share repurchase reduces the number of outstanding shares, which can potentially increase earnings per share (EPS) and demonstrate management's confidence in the company's valuation.
  • For Idea Men, LLC, the transaction provides significant liquidity, realizing $29,400,000 in cash from their investment.

Negatives

  • For GoodRx Holdings, Inc., the repurchase utilizes $29.4 million in cash that could otherwise be used for other corporate purposes such as investments, debt reduction, or acquisitions.
  • For Idea Men, LLC, the sale significantly reduces their ownership stake and potential future influence in GoodRx Holdings, Inc.

Risks

  • Idea Men, LLC is subject to a lock-up agreement, restricting their ability to sell, transfer, or hedge additional shares of Class A or Class B Common Stock until after the public release of GoodRx's Q1 2025 earnings.

Future Outlook

The Reporting Person, Idea Men, LLC, is restricted from selling, transferring, or hedging additional shares of Class A or Class B Common Stock until after the public release of GoodRx Holdings, Inc.'s earnings data for the quarter ended March 31, 2025.

Industry Context

This transaction represents a specific capital allocation decision by GoodRx Holdings, Inc. and a portfolio adjustment by a significant shareholder. While share repurchases are a common corporate finance strategy across industries to return value to shareholders or manage share count, this filing does not provide broader industry-specific trends or competitive analysis.

Related Party Transactions

  • The transaction involves the Issuer (GoodRx Holdings, Inc.) repurchasing shares from Idea Men, LLC, which is a significant beneficial owner holding 32.31% of the Class A Common Stock prior to the repurchase, indicating a related party transaction.

Stakeholder Impact

  • Shareholders: The repurchase reduces the total number of outstanding shares, which could potentially increase earnings per share (EPS) for remaining shareholders and may signal management's belief that the stock is undervalued.
  • Idea Men, LLC (Reporting Person): Realizes $29.4 million in cash proceeds but reduces its ownership stake and voting power in GoodRx Holdings, Inc.

Next Steps

  • The March 2025 Repurchase is expected to close on March 21, 2025.
  • The lock-up period for Idea Men, LLC will expire after the public release of GoodRx Holdings, Inc.'s earnings data for the quarter ended March 31, 2025.

Key Dates

DateDescription
2021-06-01Original Schedule 13D filing date.
2025-03-16Date of the Stock Purchase Agreement between GoodRx Holdings, Inc. and Idea Men, LLC.
2025-03-18Date of this Amendment No. 4 to Schedule 13D filing.
2025-03-21Expected closing date of the March 2025 Repurchase.
2025-03-31End of the quarter for which earnings data release will trigger the end of the lock-up period for Idea Men, LLC.

Recommendation

hold

Keywords

GoodRx Holdings, Idea Men LLC, Stock Repurchase, Share Buyback, SEC Filing, Schedule 13D, Class A Common Stock, Corporate Governance, Shareholder Agreement

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.